When to Initiate Weight Loss Medications in the NAFLD Population

Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steatosis, lobular inflammation, ballooning degeneration and hepatic fibrosis in the absence of significant alcohol use and other known causes of chronic liver diseases. NAFLD is subdivided into nonalcoholi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Eric R., Sallam, Sandy, Perumpail, Brandon J., Iqbal, Umair, Shah, Neha D., Kwong, Waiyee, Cholankeril, George, Kim, Donghee, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313489/
https://www.ncbi.nlm.nih.gov/pubmed/30274326
http://dx.doi.org/10.3390/diseases6040091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313489/
https://www.ncbi.nlm.nih.gov/pubmed/30274326
http://dx.doi.org/10.3390/diseases6040091

Ejemplares similares